FDA NDC Directory · JSON-LD · Markdown

Deferoxamine

NDC 63323-599 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameDEFEROXAMINE MESYLATE
Labeler / ManufacturerFresenius Kabi USA, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA078718
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Active ingredientsDEFEROXAMINE MESYLATE (95 mg/mL)
Marketing started20091215
Package count1

External sources

Source: openFDA. Public-domain (CC0).